Masimo Gross Profit 2007-2019 | MASI

Masimo annual/quarterly gross profit history and growth rate from 2007 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Masimo gross profit for the quarter ending March 31, 2019 was $0.152B, a 5.56% increase year-over-year.
  • Masimo gross profit for the twelve months ending March 31, 2019 was $0.583B, a 9.3% increase year-over-year.
  • Masimo annual gross profit for 2018 was $0.575B, a 10.13% increase from 2017.
  • Masimo annual gross profit for 2017 was $0.522B, a 9.13% increase from 2016.
  • Masimo annual gross profit for 2016 was $0.478B, a 16.67% increase from 2015.
Masimo Annual Gross Profit
(Millions of US $)
2018 $575
2017 $522
2016 $478
2015 $410
2014 $391
2013 $359
2012 $326
2011 $294
2010 $286
2009 $249
2008 $218
2007 $183
2006 $163
2005 $65
Masimo Quarterly Gross Profit
(Millions of US $)
Q1 2019 $152
Q4 2018 $148
Q3 2018 $141
Q2 2018 $142
Q1 2018 $144
Q4 2017 $139
Q3 2017 $124
Q2 2017 $127
Q1 2017 $132
Q4 2016 $139
Q3 2016 $110
Q2 2016 $115
Q1 2016 $114
Q4 2015 $102
Q3 2015 $102
Q2 2015 $103
Q1 2015 $103
Q4 2014 $109
Q3 2014 $96
Q2 2014 $93
Q1 2014 $92
Q4 2013 $91
Q3 2013 $87
Q2 2013 $91
Q1 2013 $90
Q4 2012 $87
Q3 2012 $78
Q2 2012 $81
Q1 2012 $79
Q4 2011 $74
Q3 2011 $68
Q2 2011 $75
Q1 2011 $77
Q4 2010 $74
Q3 2010 $72
Q2 2010 $70
Q1 2010 $70
Q4 2009 $66
Q3 2009 $62
Q2 2009 $60
Q1 2009 $61
Q4 2008 $59
Q3 2008 $56
Q2 2008 $53
Q1 2008 $50
Q4 2007 $49
Q3 2007 $46
Q2 2007 $46
Q1 2007 $42
Q3 2006 $43
Q2 2006 $41
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $8.237B $0.858B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $115.527B 25.27
Intuitive Surgical (ISRG) United States $60.928B 56.14
Edwards Lifesciences (EW) United States $39.801B 39.77
IDEXX Laboratories (IDXX) United States $24.444B 64.13
Fresenius Medical Care AG KGaA (FMS) Germany $24.394B 16.03
Teleflex (TFX) United States $15.460B 33.50
Olympus (OCPNY) Japan $15.407B 115.28
SONOVA HOLDING (SONVY) Switzerland $14.561B 0.00
Sysmex ADR (SSMXY) Japan $14.417B 38.87
DexCom (DXCM) United States $13.759B 269.84
Hologic (HOLX) United States $12.689B 20.41
STERIS (STE) Ireland $12.575B 30.42
Varian Medical Systems (VAR) United States $12.300B 31.38
ABIOMED (ABMD) United States $11.800B 71.79
Penumbra (PEN) United States $6.000B 254.01
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.153B 38.83
Integra LifeSciences Holdings (IART) United States $4.599B 21.61
Globus Medical (GMED) United States $4.096B 25.54
Tandem Diabetes Care (TNDM) United States $3.740B 0.00
LivaNova (LIVN) United Kingdom $3.605B 23.50
Wright Medical Group (WMGI) Netherlands $3.365B 667.00
Cantel Medical (CMD) United States $3.364B 34.13
Glaukos (GKOS) United States $2.750B 0.00
Integer Holdings (ITGR) United States $2.675B 19.71
Nihon Kohden (NHNKY) Japan $2.449B 24.64
AVANOS MEDICAL, INC (AVNS) United States $2.029B 32.12
Nevro (NVRO) United States $1.983B 0.00
Inogen (INGN) United States $1.373B 30.40
OPKO Health (OPK) United States $1.317B 0.00
Silk Road Medical (SILK) United States $1.239B 0.00
Veracyte (VCYT) United States $1.167B 0.00
CryoLife (CRY) United States $1.116B 110.70
Accelerate Diagnostics (AXDX) United States $1.055B 0.00
Tactile Systems Technology (TCMD) United States $1.032B 152.33
ORTHOFIX MEDICAL INC (OFIX) United States $0.983B 28.48
Mesa Laboratories (MLAB) United States $0.912B 42.88
Pacific Biosciences Of California (PACB) United States $0.910B 0.00
ViewRay (VRAY) United States $0.907B 0.00
Luminex (LMNX) United States $0.882B 115.35
Natus Medical (BABY) United States $0.880B 20.37
AngioDynamics (ANGO) United States $0.810B 26.55
AxoGen (AXGN) United States $0.767B 0.00
Fluidigm (FLDM) United States $0.759B 0.00
Quotient (QTNT) Switzerland $0.696B 0.00
Intersect ENT (XENT) United States $0.651B 0.00
Corindus Vascular Robotics (CVRS) United States $0.581B 0.00
OrthoPediatrics (KIDS) United States $0.541B 0.00
Si-Bone (SIBN) United States $0.483B 0.00
GenMark Diagnostics (GNMK) United States $0.361B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.354B 18.99
RTI Surgical (RTIX) United States $0.312B 38.36
Accuray (ARAY) United States $0.309B 0.00
TransEnterix (TRXC) United States $0.304B 0.00
Semler Scientific (SMLR) United States $0.289B 57.37
SeaSpine Holdings (SPNE) United States $0.245B 0.00
Neuronetics (STIM) United States $0.235B 0.00
ConforMIS (CFMS) United States $0.231B 0.00
Alphatec Holdings (ATEC) United States $0.208B 0.00
IRadimed (IRMD) United States $0.203B 38.64
CRH Medical (CRHM) Canada $0.201B 69.75
Sientra (SIEN) United States $0.180B 0.00
Stereotaxis (STXS) United States $0.172B 0.00
Second Sight Medical Products (EYES) United States $0.100B 0.00
Ekso Bionics Holdings (EKSO) United States $0.093B 0.00
Sensus Healthcare (SRTS) United States $0.088B 0.00
Vermillion (VRML) United States $0.086B 0.00
EDAP TMS S.A (EDAP) France $0.078B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
T2 Biosystems (TTOO) United States $0.069B 0.00
Apollo Endosurgery (APEN) United States $0.066B 0.00
Spectral Diagnostics (EDTXF) Canada $0.066B 0.00
Helius Medical Technologies (HSDT) United States $0.053B 0.00